All Updates

All Updates

icon
Filter
Funding
Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts
Cell-cultured Meat
Jun 6, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
Cell-cultured Meat

Cell-cultured Meat

Jun 6, 2024

Prolific Machines raises USD 55 million in Series B funding to begin commercialization efforts

Funding

  • Prolific Machines, a biotechnology company specializing in photo molecular biology, has raised USD 54.6 million in series B funding led by The Ki Tua Fund. Breakthrough Energy Ventures, Mayfield, SOSV, Shorewind Capital, Darco Capital, Conti Ventures, and In-Q-Tel (IQT) participated.

  • Prolific Machines will use the funding for commercialization and customer acquisition, marking the company’s transition from proving the efficacy of its process to actively delivering it to people. 

  • Prolific Machines enable the transition from expensive and hard-to-control molecules to a more efficient and sustainable method—light. Through its bioreactors, it offers customers efficient biomanufacturing of high-value bioproducts, including nutritional proteins, antibodies for disease treatment, and cultivated meat.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.